Current and historical daily PE Ratio for TELO (
Telomir Pharmaceuticals Inc
) from 2024 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Telomir Pharmaceuticals stock (TELO) PE ratio as of Jun 06 2024 is 0.
More Details
Telomir Pharmaceuticals Inc (TELO) PE Ratio (TTM) Chart
Telomir Pharmaceuticals Inc (TELO) PE Ratio (TTM) Historical Data
View and export this data going back to 2024. Start your Free Trial
Total 83
- 1
| Telomir Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-07 | At Loss | 2024-04-10 | At Loss |
| 2024-06-06 | At Loss | 2024-04-09 | At Loss |
| 2024-06-05 | At Loss | 2024-04-08 | At Loss |
| 2024-06-04 | At Loss | 2024-04-05 | At Loss |
| 2024-06-03 | At Loss | 2024-04-04 | At Loss |
| 2024-05-31 | At Loss | 2024-04-03 | At Loss |
| 2024-05-30 | At Loss | 2024-04-02 | At Loss |
| 2024-05-29 | At Loss | 2024-04-01 | At Loss |
| 2024-05-28 | At Loss | 2024-03-28 | At Loss |
| 2024-05-24 | At Loss | 2024-03-27 | At Loss |
| 2024-05-23 | At Loss | 2024-03-26 | At Loss |
| 2024-05-22 | At Loss | 2024-03-25 | At Loss |
| 2024-05-21 | At Loss | 2024-03-22 | At Loss |
| 2024-05-20 | At Loss | 2024-03-21 | At Loss |
| 2024-05-17 | At Loss | 2024-03-20 | At Loss |
| 2024-05-16 | At Loss | 2024-03-19 | At Loss |
| 2024-05-15 | At Loss | 2024-03-18 | At Loss |
| 2024-05-14 | At Loss | 2024-03-15 | At Loss |
| 2024-05-13 | At Loss | 2024-03-14 | At Loss |
| 2024-05-10 | At Loss | 2024-03-13 | At Loss |
| 2024-05-09 | At Loss | 2024-03-12 | At Loss |
| 2024-05-08 | At Loss | 2024-03-11 | At Loss |
| 2024-05-07 | At Loss | 2024-03-08 | At Loss |
| 2024-05-06 | At Loss | 2024-03-07 | At Loss |
| 2024-05-03 | At Loss | 2024-03-06 | At Loss |
| 2024-05-02 | At Loss | 2024-03-05 | At Loss |
| 2024-05-01 | At Loss | 2024-03-04 | At Loss |
| 2024-04-30 | At Loss | 2024-03-01 | At Loss |
| 2024-04-29 | At Loss | 2024-02-29 | At Loss |
| 2024-04-26 | At Loss | 2024-02-28 | At Loss |
| 2024-04-25 | At Loss | 2024-02-27 | At Loss |
| 2024-04-24 | At Loss | 2024-02-26 | At Loss |
| 2024-04-23 | At Loss | 2024-02-23 | At Loss |
| 2024-04-22 | At Loss | 2024-02-22 | At Loss |
| 2024-04-19 | At Loss | 2024-02-21 | At Loss |
| 2024-04-18 | At Loss | 2024-02-20 | At Loss |
| 2024-04-17 | At Loss | 2024-02-16 | At Loss |
| 2024-04-16 | At Loss | 2024-02-15 | At Loss |
| 2024-04-15 | At Loss | 2024-02-14 | At Loss |
| 2024-04-12 | At Loss | 2024-02-13 | At Loss |
| 2024-04-11 | At Loss | 2024-02-12 | At Loss |
Telomir Pharmaceuticals Inc (TELO) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Telomir Pharmaceuticals Inc
NAICS : 541713
SIC : 2834
ISIN : US87975F1049
Description
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers